Virginia Retirement Systems Et Al Glaukos Corp Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	BUY	$46.84 - $58.49 $37,472 - $46,792	800 Added 16.67%	5,600 $298 Million
Q4 2021 Feb 03, 2022	BUY	$40.27 - $56.99 $20,135 - $28,495	500 Added 11.63%	4,800 $213,000
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $314,158 - $420,110	4,300 New	4,300 $365,000
Q3 2019 Oct 22, 2019	SELL	$58.58 - $83.91 $521,362 - $746,799	-8,900 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$63.59 - $78.71 $565,951 - $700,519	8,900 New	8,900 $671,000

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.